Business areas
DR.Cure focuses on the development of radiotherapeutic nanoparticles, pioneering innovative cancer treatment technologies.
We lead medical innovation through nanotherapeutics, drug delivery systems, and personalized treatment solutions.
We lead medical innovation through nanotherapeutics, drug delivery systems, and personalized treatment solutions.
Technology Area 01
Precision Nano-Anticancer
Therapy Solution
Therapy Solution
We are developing next-generation nanoparticle-based
radiosensitizers that selectively target tumor tissues.
Our platform, featuring high tumor specificity and image
contrast enhancement, offers a new standard
for precision oncology by overcoming the limitations
of conventional treatments.
radiosensitizers that selectively target tumor tissues.
Our platform, featuring high tumor specificity and image
contrast enhancement, offers a new standard
for precision oncology by overcoming the limitations
of conventional treatments.
Technology Area 02
Hypoxia-Modulating Liver
Cancer Therapy Platform
Cancer Therapy Platform
Utilizing smart nanoparticles that regulate hypoxic
conditions within tumors, this platform enhances
the effectiveness of radiotherapy by reducing
resistance and enabling more efficient
therapeutic response.
conditions within tumors, this platform enhances
the effectiveness of radiotherapy by reducing
resistance and enabling more efficient
therapeutic response.
Technology Area 03
Renal Inflammatory Disease
Therapeutics Platform
Therapeutics Platform
Based on a nanocomposite that suppresses inflammation
and modulates pathological macrophage infiltration, this
innovative drug delivery system is tailored for kidney diseases.
Its technological capabilities have been validated through
international patents and peer-reviewed publications.
and modulates pathological macrophage infiltration, this
innovative drug delivery system is tailored for kidney diseases.
Its technological capabilities have been validated through
international patents and peer-reviewed publications.
